Sufentanil citrate
- Level
- Commodity
- Parent
- 51273000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51273024This classification denotes an opioid receptor agonist and opioid with the molecular formula C22H30N2O2S.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S9ZFX8403R, chemically known as propanamide, n-(4-(methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-n-phenyl- but more generally known as sufentanil citrate, which bears US NIH Compound Identifier 41693. European Medicines Agency schedules Sufentanil citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04616MIG. Most nations, for tariff and trade purposes, schedule sufentanil citrate under HS 29349100 and SITC 51579. As of Q4 2014, SUFENTANIL CITRATE remains US FDA's Preferred Term for this commodity. Sufentanil citrate bears US NLM identifiers UMLS ID C0733851 and NCI Concept Code C47731. SMILES: CCC(=O)N(C1CCCCC1)C2(CCN(CC2)CCC3CCCS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.
Same parent
Under 51273000 · 24Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.